Tenboron
Helsinki
About Tenboron
Tenboron is biochemically targeted radiation therapy. They offer services for boron neutron capture therapy designed to treat locally invasive malignant tumors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $4.9M
- Last round: Series Unknown (May 2019)
- Website: tenboron.fi
- Phone: [email protected]
Industries & Categories
Biotechnology, Consulting, Health Care
Social Profiles
Canonical: https://fsome.com/organization/tenboron-154461 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.